Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell–specific manner
Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani
Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani
View: Text | PDF
Research Article Immunology

Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell–specific manner

  • Text
  • PDF
Abstract

Hematopoietic protein-1 (Hem-1) is a member of the actin-regulatory WASp family verprolin homolog (WAVE) complex. Loss-of-function variants in the NCKAP1L gene encoding Hem-1 were recently discovered to result in primary immunodeficiency disease (PID) in children, characterized by poor specific Ab responses, increased autoantibodies, and high mortality. However, the mechanisms of how Hem-1 deficiency results in PID are unclear. In this study, we utilized constitutive and B cell–specific Nckap1l-KO mice to dissect the importance of Hem-1 in B cell development and functions. B cell–specific disruption of Hem-1 resulted in reduced numbers of recirculating follicular (FO), marginal zone (MZ), and B1 B cells. B cell migration in response to CXCL12 and -13 were reduced. T-independent Ab responses were nearly abolished, resulting in failed protective immunity to Streptococcus pneumoniae challenge. In contrast, T-dependent IgM and IgG2c, memory B cell, and plasma cell responses were more robust relative to WT control mice. B cell–specific Hem-1–deficient mice had increased autoantibodies against multiple autoantigens, and this correlated with hyperresponsive BCR signaling and increased representation of CD11c+T-bet+ age-associated B cell (ABC cells) — alterations associated with autoimmune diseases. These results suggest that dysfunctional B cells may be part of a mechanism explaining why loss-of-function Hem-1 variants result in recurring infections and autoimmunity.

Authors

Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani

×

Figure 2

B cell–specific disruption of Hem-1 results in a reduction of mature recirculating follicular B cells.

Options: View larger image (or click on image) Download as PowerPoint
B cell–specific disruption of Hem-1 results in a reduction of mature rec...
Total BM cells were isolated from BM of 6- to 12-week-old Hem1fl/flMb1Cre and WT littermate mice, followed by staining with fluorescent conjugated antibodies against the indicated surface markers and flow cytometric analyses. (A) Representative dot-plot histograms. (B) Bar graphs with percentages (top) and cell numbers (bottom) of B cell populations falling within Hardy fractions A–F. Each data point represents individual mice, and graphs are representative of > 5 independent experiments (n = 22 and n = 20). (C) Peripheral blood samples were isolated from WT and Hem1fl/flMb1Cre mice, followed fluorescent Ab staining against the indicated surface markers and flow cytometric analyses. Shown are representative flow cytometric contour histograms (left) and bar graphs with quantification (right) of the proportions of T0 (B220+CD93+IgM+IgD–CD23–), T1 (B220+CD93+IgM+IgD+CD23–), and T2 (B220+CD93+IgM+IgD+CD23+) B cells in peripheral blood. Each data point is representative of a single mouse, and data were collected from 2 independent experiments (n = 6 and n = 5). Data represent mean ± SEM and were analyzed via unpaired Student’s t test. *P < 0.05, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts